Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quinoline-Based Molecules Targeting c-Met, EGF, and VEGF Receptors and the Proteins Involved in Related Carcinogenic Pathways
Annamaria Martorana, Gabriele La Monica, Antonino Lauria
Molecules (2020) Vol. 25, Iss. 18, pp. 4279-4279
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Recent advances in chemistry and therapeutic potential of functionalized quinoline motifs – a review
Olayinka O. Ajani, King T. Iyaye, Olabisi Theresa Ademosun
RSC Advances (2022) Vol. 12, Iss. 29, pp. 18594-18614
Open Access | Times Cited: 132
Quinoline anticancer agents active on DNA and DNA-interacting proteins: From classical to emerging therapeutic targets
Antonino Lauria, Gabriele La Monica, Alessia Bono, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113555-113555
Closed Access | Times Cited: 61
Computational targeting of allosteric site of MEK1 by quinoline‐based molecules
Rahul Singh, Vijay Kumar Bhardwaj, Rituraj Purohit
Cell Biochemistry and Function (2022) Vol. 40, Iss. 5, pp. 481-490
Closed Access | Times Cited: 58
Design and biological evaluation of 3-substituted quinazoline-2,4(1 H ,3 H )-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors
Abdelfattah Hassan, Fawzy A. F. Mubarak, Ihsan A. Shehadi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 19
Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer
Parham Jabbarzadeh Kaboli, Hsiao‐Fan Chen, Ali Babaeizad, et al.
Cancer Letters (2024) Vol. 588, pp. 216780-216780
Closed Access | Times Cited: 11
An insight into sustainable and green chemistry approaches for the synthesis of quinoline derivatives as anticancer agents
B. Kumaraswamy, K. Hemalatha, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116561-116561
Closed Access | Times Cited: 7
Clioquinol inhibits angiogenesis by promoting VEGFR2 degradation and synergizes with AKT inhibition to suppress triple-negative breast cancer vascularization
Yuan Gu, Tianci Tang, Moqin Qiu, et al.
Angiogenesis (2025) Vol. 28, Iss. 2
Open Access
Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways
Jiaojiao Yu, Lijing Zhang, Jun Peng, et al.
Biochemical Pharmacology (2021) Vol. 195, pp. 114864-114864
Open Access | Times Cited: 40
Design, synthesis, and biological evaluation of novel quinoline derivatives as small molecule mutant EGFR inhibitors targeting resistance in NSCLC: In vitro screening and ADME predictions
Ramakant A. Kardile, Aniket P. Sarkate, Deepak K. Lokwani, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114889-114889
Closed Access | Times Cited: 29
Bioisosteric heterocyclic analogues of natural bioactive flavonoids by scaffold-hopping approaches: State-of-the-art and perspectives in medicinal chemistry
Gabriele La Monica, Alessia Bono, Federica Alamia, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 109, pp. 117791-117791
Open Access | Times Cited: 5
Saturation Transfer Difference NMR and Molecular Docking Interaction Study of Aralkyl-Thiodigalactosides as Potential Inhibitors of the Human-Galectin-3 Protein
Fanni Hőgye, László Bence Farkas, Álex Kálmán Balogh, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1742-1742
Open Access | Times Cited: 3
New proapoptotic chemotherapeutic agents based on the quinolone-3-carboxamide scaffold acting by VEGFR-2 inhibition
Zeinab S. El-Fakharany, Yassin M. Nissan, Nada K. Sedky, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Design, synthesis, in vitro antiproliferative evaluation and in silico studies of new VEGFR-2 inhibitors based on 4-piperazinylquinolin-2(1H)-one scaffold
Abdelfattah Hassan, Mohamed Badr, Dalia Abdelhamid, et al.
Bioorganic Chemistry (2022) Vol. 120, pp. 105631-105631
Closed Access | Times Cited: 15
Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B
Gang Lv, Qiong Shi, Ting Zhang, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 80, pp. 117173-117173
Closed Access | Times Cited: 8
Iron-Catalyzed Oxidative Cyclization of 2-Amino Styrenes with Alcohols and Methyl Arenes for the Synthesis of Polysubstituted Quinolines
Seok Beom Lee, Simin Chun, Seung Hyun Choi, et al.
The Journal of Organic Chemistry (2023) Vol. 88, Iss. 13, pp. 8099-8113
Closed Access | Times Cited: 8
Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges
Pengxiao Su, Ming Zhang, Xin Kang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Small Molecule Inhibitors Targeting the “Undruggable” Survivin: The Past, Present, and Future from a Medicinal Chemist’s Perspective
Qingbin Cui, Caoqinglong Huang, Jingyuan Liu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 24, pp. 16515-16545
Closed Access | Times Cited: 7
Structure-based pharmacophore mapping and virtual screening of natural products to identify polypharmacological inhibitor against c-MET/EGFR/VEGFR-2
Diksha A. Varma, Mrityunjay Singh, Sharad Wakode, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 7, pp. 2956-2970
Closed Access | Times Cited: 12
Design and green synthesis of novel quinolinone derivatives of potential anti-breast cancer activity against MCF-7 cell line targeting multi-receptor tyrosine kinases
Mohamed Mokhtar, Khadijah Saad Al-Ghamdi, Nesreen S. Ahmed, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1453-1470
Open Access | Times Cited: 14
Design and development of photoswitchable DFG-Out RET kinase inhibitors
Yongjin Xu, Chunxia Gao, Måns Andréasson, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114226-114226
Open Access | Times Cited: 9
The Anticancer Effect of a Novel Quinoline Derivative 91b1 through Downregulation of Lumican
Yuanyuan Zhou, Zhongguo Zhou, Dessy Chan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13181-13181
Open Access | Times Cited: 9
Synthesis and biological evaluation of novel 2-morpholino-4-anilinoquinoline derivatives as antitumor agents against HepG2 cell line
Ahmed Al‐Sheikh, Malak A. Jaber, Hana'a Khalaf, et al.
RSC Advances (2024) Vol. 14, Iss. 5, pp. 3304-3313
Open Access | Times Cited: 1
Effective Microwave-Assisted Synthesis of 2-Chloro-5,6-dimethyl-3-(((substituted-benzylidene)hydrazono)methyl)-quinoline and Its Biological Assessment
Niyati K. Vegal, Tara Bhatt, Kanji D. Kachhot, et al.
Russian Journal of Bioorganic Chemistry (2024) Vol. 50, Iss. 1, pp. 239-250
Closed Access | Times Cited: 1
Redefining the significance of quinoline containing compounds as potent VEGFR-2 inhibitors for cancer therapy
Jurnal Reang, Vinita Sharma, Vivek Yadav, et al.
Medicinal Chemistry Research (2024) Vol. 33, Iss. 7, pp. 1079-1099
Closed Access | Times Cited: 1
Design, synthesis and anticancer evaluation of novel arylhydrazones of active methylene compounds
Akshaya Murugesan, Konda Mani Saravanan, Shabnaz Koochakkhani, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127909-127909
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top